The JuxtaFlow® Renal Assist Device (RAD)
Roivios is developing a breakthrough treatment to sustain or enhance kidney function for patients with pre-existing renal impairment undergoing a cardiac surgery with cardiopulmonary bypass – the world’s first renal assist device (RAD).
The JuxtaFlow Renal Assist Device (RAD) transmits a mild, targeted negative pressure designed to sustain or enhance kidney function in times of acute stress.
Caution – Investigational Device, Limited by United States Law to Investigational Use Only. Not available for sale in the United States.
It is our mission to prove that the JuxtaFlow Renal Assist Device (RAD) provides an important bridge to recovery and, ultimately, improved patient outcomes.
The JuxtaFlow Renal Assist Device (RAD) System
The JuxtaFlow catheter
- Proprietary catheter delivers targeted treatment
- Comfortably rests in renal pelvis
The JuxtaFlow pump
- Simple and intuitive interface
- Self-regulating pressure control
How the JuxtaFlow Renal Assist Device (RAD) System Works
Introduce Negative Pressure
1
The JuxtaFlow System delivers targeted negative pressure to the renal collecting system.
- The JuxtaFlow catheters are inserted by a trained urologist similar to ureteral stent placement.
- The catheters connect to the JuxtaFlow pump to deliver mild, targeted negative pressure.
Enhance Pressure Balance
2
The negative pressure is designed to enhance the filtration gradient.
- The negative pressure is designed to transmit throughout the nephrons, reducing downstream hydrostatic pressure.
- Controlled pressure reduction allows for effective filtration and selective reabsorption.
Optimize Kidney Function
3
The goal is to optimize renal function in the recovery period.
- The JuxtaFlow System enhances filtration and reabsorption, mitigating the effects of kidney stressors.
Learn about our research
Find info about our clinical studies
Meet our Team
See what makes us different
Contact Us
Connect with our team
